TOI — Oncology Institute Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Oncology Institute, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-14.3	-10.9	0.152	-83.1	-64.7
Depreciation
Deferred Taxes
Non-Cash Items	12	-9.36	-45.9	38.6	13.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.992	-14.5	-20.2	2.36	18.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	0.508	-32.7	-61.8	-36.3	-26.5
Capital Expenditures	-1.19	-3.05	-5.53	-4.57	-3.79
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7.65	-9.11	-126	67.2	50
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-8.84	-12.2	-132	62.6	46.2
Financing Cash Flow Items	-0.343	141	-5.93	-5.85	-3.53
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11.9	154	92.2	-6.85	-3.49
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3.55	109	-101	19.5	16.2